Baron Health Care Fund: Q3 2026 New Positions And Exits

During the quarter, we added 4 new positions and exited 14, bringing the number of positions in the Fund to 33. We initiated a position in Biogen Inc., a company that we believe is in the early stages of a transformation. We sold Madrigal Pharmaceuticals, Inc. to manage risk ahead of a competitor's clinical trial readout.

Seeking Alpha • Oct 26, 2026

Humana Gains From Premium Growth Despite Rising Benefit Costs

HUM's surging premiums, Medicare Advantage growth and CenterWell expansion bolster its prospects, but rising benefit costs and expenses pose challenges.

Zacks Investment Research • Oct 21, 2026

Should Value Investors Buy Humana (HUM) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Oct 19, 2026

3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking

Retirement planning gets harder when healthcare coverage becomes a moving target. A familiar insurance card can mean access to trusted doctors, predictable prescription costs, and benefits that help stretch a fixed income.

24/7 Wall Street • Oct 19, 2026

Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital

HUM's CenterWell venture with BlackRock brings $2.8 billion in capital, easing balance sheet liabilities and supporting clinic expansion.

Zacks Investment Research • Oct 14, 2026

Humana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga • Oct 13, 2026

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

PRNewsWire • Oct 13, 2026

Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackRock (“BlackRock”), to manage and operate an existing network of nearly 150 CenterWell Senior Primary Care clinics that currently sit within joint ventures owned by funds affiliated with WCAS and CenterWell. The new joint venture, majority owned by BlackRock and minority owned by CenterWell, will rep.

Business Wire • Oct 13, 2026

Humana Hits 95% Four-Star Coverage: What it Means for HUM

Humana's 2027 Medicare Advantage ratings rebound puts 95% of members in four-star or better plans, potentially boosting 2028 bonus payments and plan benefits.

Zacks Investment Research • Oct 12, 2026

Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2026 (3Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 6, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 3Q26 earnings call may be accessed via Humana's Investor Relations page at.

Business Wire • Oct 12, 2026